Authors

Zachary Epstein-Peterson, MD, is a lymphoma specialist at Memorial Sloan Kettering Cancer Center in New York, NY.

Lucy Langer, MD is the practice president director of Genetic Risk Evaluation and Testing Compass Oncology , and the medical director of Cancer Genetics atThe US Oncology Network in The Woodlands, Texas.

Robert Galamaga, DO, is the medical director of Outpatient Care Centers and a medical oncologist at Cancer Treatment Centers of America® (CTCA) Phoenix.

Inhye E. Ahn, MD, is an assistant professor of medicine at the Dana-Farber Cancer Institute in Boston, MA.

Kaveh Zakeri, MD, MAS, is a radiation oncologist in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. Zakeri specializes in head and neck cancers, skin cancer, lung caners, palliative care, and metastatic disease.

Kelly Chien, MD, is an assistant Professor in the department of leukemia, division of cancer medicine, The University of Texas MD Anderson Cancer Center, in Houston, TX.

Rupesh J. Parikh, MD, is a medical oncologist for Comprehensive Cancer Centers in Henderson, Nevada.

Aaron S. Farberg, MD of Texas Dermatology Associates, is a board-certified dermatologist and Mohs surgeon that specializes in skin cancer and cosmetic dermatology.

Katherine E. Poruk, MD, is a board-certified and fellowship-trained surgical oncologist at Cancer Treatment Centers of America® (CTCA) Atlanta.

Olsi Gjyshi, MD, is a staff radiation oncologist at St Elizabeth Healthcare